The way to build bridges instead of walls is still long, but I am happy to have got European Union funding for this project. Africlinique project aims to increase the capacity to oversight clinical trials addressing deadly diseases in Central African countries (specifically Republic of the Congo, Democratic Republic of the Congo, Cameroon and Gabon). This achievement was made possible thanks to the exciting proactiveness and invaluable collaboration of a Central African team lead by Prof. Francine Ntoumi, already coordinator of Central Africa Network on Tuberculosis, HIV/AIDS and Malaria (CANTAM).

Leave a Reply

Your email address will not be published. Required fields are marked *

Explore More

Second European-African training for the Congolese team on “SARS-CoV-2 detection by ApoH enzyme”

As part of the implementation of ITAIL-COVID-19 project funded by the European Development Countries Partnership for Clinical Trials (EDCTP) and coordinated by the Congolese Foundation for Medical Research (FCRM), the

ImproViTB

With 1 million new cases and 200,000 children dead each year, Tuberculosis (TB) is now the leading cause of death from infectious diseases for children of all ages globally (UNICEF).

The COVID-19 pandemic threatens to reverse recent progress in reducing the global burden of Tuberculosis

The COVID-19 pandemic threatens to reverse recent progress in reducing the global burden of tuberculosis. The global number of deaths for tuberculosis could increase by around 200.000–400.000 in 2020 alone,